Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Intelligent Bio Solutions Inc. (INBS)

2.2099 -0.1701 (-7.25%)
As of 9:40:05 AM EDT. Market Open.
Chart Range Bar
Loading chart for INBS
  • Previous Close 2.3800
  • Open 2.4000
  • Bid 1.7800 x 200
  • Ask 2.6800 x 1000
  • Day's Range 2.0501 - 2.5300
  • 52 Week Range 1.5200 - 24.9000
  • Volume 3,841,147
  • Avg. Volume 80,426
  • Market Cap (intraday) 6.69M
  • Beta (5Y Monthly) 4.21
  • PE Ratio (TTM) --
  • EPS (TTM) -8.4400
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 12.00

Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York.

ibs.inc

59

Full Time Employees

June 30

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 9/1/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

INBS
76.81%
S&P 500 (^GSPC)
11.50%

1-Year Return

INBS
86.36%
S&P 500 (^GSPC)
18.14%

3-Year Return

INBS
98.96%
S&P 500 (^GSPC)
69.02%

5-Year Return

INBS
99.98%
S&P 500 (^GSPC)
68.71%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 1.06M
Earnings -2.86M
Profit Margin -269.86%

Q3

FY24

Q4

FY24

Q3

FY26

-2M
-1M
0
1M
-380.0%
-360.0%
-340.0%
-320.0%
-300.0%
-280.0%

Analyst Insights

View More

Analyst Price Targets

12.00
12.00 Average
2.2099 Current
12.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
As of 8/27/2026
  • Market Cap

    6.93M

  • Enterprise Value

    4.76M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.80

  • Price/Book (mrq)

    1.26

  • Enterprise Value/Revenue

    1.13

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -294.91%

  • Return on Assets (ttm)

    -76.20%

  • Return on Equity (ttm)

    -307.69%

  • Revenue (ttm)

    4.22M

  • Net Income Avi to Common (ttm)

    -12.43M

  • Diluted EPS (ttm)

    -8.4400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.14M

  • Total Debt/Equity (mrq)

    34.38%

  • Levered Free Cash Flow (ttm)

    -6.72M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

2.2099 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: